Lactated Ringer’s Injection 500mL

Lactated Ringer’s Injection 500mL: What the Published Guidance Says

Crystalloid infusion solutions, energy substrates and parenteral nutrition components — the fluid-resuscitation and supportive-care layer underneath almost every inpatient protocol.

This page collects the supply-relevant facts for Lactated Ringer’s Injection 500mL — specification, testing, packaging and the registration paperwork that travels with the batch.

• Electrolyte composition is what separates saline from balanced solutions The Model List publishes the electrolyte content of each crystalloid it carries: sodium chloride 0.9% at Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L, the 5% + 0.9% glucose/sodium chloride combination at 150 mmol/L, and the 5% + 0.45% combination at 75 mmol/L. Comparing those figures against plasma composition is how a formulary committee decides which fluid to standardise on — and why lactated Ringer's, with a more physiological profile, is frequently the resuscitation default. WHO eEML — Glucose + sodium chloride
• The Model List specifies the crystalloid formulations The 24th WHO Model List (2025) carries sodium chloride 0.9% isotonic (equivalent to Na⁺ 154 mmol/L and Cl⁻ 154 mmol/L) and glucose + sodium chloride combinations of 4% + 0.18%, 5% + 0.9% and 5% + 0.45%, classified under solutions correcting water, electrolyte and acid-base disturbances. Glucose + sodium chloride was first added in 1979. WHO eEML — Glucose + sodium chloride
• Presentation is part of the specification WHO's criterion for an essential medicine includes that it be available in appropriate dosage forms for the intended uses and patients. For infusion solutions that criterion is expressed as fill volume and container format — the difference between a 500 mL bottle and a 1 L bag is a formulary decision before it becomes a price decision. WHO — Essential medicines (fact sheet)

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Lactated Ringer’s Injection 500mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

How Lactated Ringer’s Injection 500mL Is Tested and Released

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of Lactated Ringer’s Injection 500mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

Release testing on this presentation is built around:

• Testing for related substances and impurities
• Testing for dissolution or release profile (solid oral forms)
• Testing for uniformity of dosage units
• Testing for water content and pH where applicable
• Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
• Testing for microbial limits and preservative efficacy (multi-dose presentations)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

How Lactated Ringer’s Injection 500mL Is Packed, Labelled and Shipped

• Pack size: 500mL sterile plastic infusion container (PVC or non-PVC flexible bag) or glass bottle with rubber stopper and aluminum seal. Non-standard pack sizes can be quoted against your artwork.
• Storage: Store below 25°C, protected from light and excessive heat. Do not freeze. Keep container in overwrap until use (for plastic bags)..
• Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
• Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
• Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Regulatory Support for Lactated Ringer’s Injection 500mL

Documents for Lactated Ringer’s Injection 500mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

• Method validation, stability protocol and the shelf-life justification for the marketed pack.
• Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
• Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
• Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
• Batch manufacturing and packaging records released for inspection on request during supplier audits.

The context for Lactated Ringer’s Injection 500mL is its place among infusion solutions and parenteral nutrition named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.